New on this website

29.06.2022

Batch recall – Angusta, Tabletten à 25 μg

Rückruf der Charge B28144 bis auf Stufe Detailhandel

27.06.2022

Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update

Licences in accordance with art. 22 para. 3 of the COVID 19 Ordinance 3

24.06.2022

Moderna applies for an authorisation extension for a coronavirus vaccine against Omicron

Spikevax®: Swissmedic launches rolling review procedure for a vaccine candidate adapted to SARS-CoV-2 variants (mRNA-1273.214)

23.06.2022

Batch recall – Softasept CHX gefärbt, Lösung zur Anwendung auf der Haut

Rückruf der Chargen 21481M05 und 22123M13 bis auf Stufe Detailhandel

22.06.2022

Regulatory Manager/in (80-100%)

Job advertisement | Division Regulatory Assessment

17.06.2022

Swissmedic information event «Regulatory & Beyond»

20 September 2022, Bern, 9.00 a.m. to 5.30 p.m.

16.06.2022

Wissenschaftliche/n Mitarbeiter/in (80-100%)

Job advertisement | Division Advanced Therapy Medicinal Products

15.06.2022

Public Summary SwissPAR – Minjuvi®

First authorisation

15.06.2022

Public Summary SwissPAR – Colibiogen Oral®

First authorisation

15.06.2022

Swissmedic approves Paxlovid for COVID-19 patients

Paxlovid from Pfizer AG granted temporary authorisation in Switzerland

14.06.2022

International cooperation on therapeutic products

First application reviewed by all five Access Consortium Authorities
Permanent link of this page
www.swissmedic.ch/updates-en
News channel of this page

Last modification 13.02.2020

Top of page